Home
About
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Science
Our Approach
The B Cell Advantage
Research
Pipeline
Investors & Media
Press Releases
News Articles
Publications & Presentations
Contact
Careers
Home
About
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Science
Our Approach
The B Cell Advantage
Research
Pipeline
Investors & Media
Press Releases
News Articles
Publications & Presentations
Contact
Careers
News
All
Press Releases
News Articles
Press Releases
December 15, 2025
Immusoft Secures FDA Orphan Drug Designation for ISP-002 in MPS II, a Progressive Lysosomal Storage Disease
Related
Publications & Presentations
December 09, 2025
Engineering B Cells With Immusoft’s Sean Ainsworth
Read More
Press Releases
PR Newswire | October 21, 2025
Immusoft Receives FDA Fast Track Designation for ISP-001, a First-in-Class Engineered B Cell Therapy for MPS I
Read More
